“Generally speaking, companies typically identify a problem or a business process that needs enhancement and then perform due diligence and an in-depth technology assessment to choose IT to apply to that situation. Historically, this is what best practice would dictate,” Eric Newmark reports for IDC Health Insights.
“Well, say ‘hello’ to the iPad, which is quickly turning this traditional wisdom on its head,” Newmark reports. “While tablet PCs have been used in the field within pharma sales for quite some time to enable electronic signature capture and more interactive display of edetailing information, the explosion of next-generation tablet devices like the iPad has rocked the boat in this space.”
Advertisement: Students, parents and Faculty save up to $200 on a new Mac.
Newmark reports, “The pharmaceutical sales community is now undergoing an enormous shift, with widespread interest in transitioning toward HTML5-based tablet devices like the iPad, as the industry seeks a quicker, lighter, and more attractive way of displaying drug-related information. Two things in particular make this trend interesting: the purchasing behavior of companies regarding these devices and the monopolistic iPad mindset prevailing in this space.”
“Beyond pharmas’ overwhelming interest in embracing HTML5-based tablets, what makes the phenomenon even more interesting is that most pharmas with plans to adopt these devices are planning to purchase the iPad, with little current interest in seriously evaluating competing devices from other vendors,” Newmark reports. “Based on interviews recently conducted with more than 20 pharmaceutical companies regarding CRM and SFA planned investment, all stated they believe Apple will remain the lead innovator in the space and that deploying SFA on the iPad (rather than a competing tablet device) is safer long term because it will help ensure they keep up with the latest technology developments and innovations. Only 3 of 20 companies mentioned they planned to spend any significant time reviewing competing solutions.”
Read more in the full article (.pdf) here.
[Thanks to MacDailyNews Reader “Brian” for the heads up.]